These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3287705)

  • 1. A model to account for the variation in cyclosporin binding to plasma lipids in transplant patients.
    Legg B; Gupta SK; Rowland M
    Ther Drug Monit; 1988; 10(1):20-7. PubMed ID: 3287705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin: erythrocyte binding and an examination of its use to estimate unbound concentration.
    Legg B; Rowland M
    Ther Drug Monit; 1988; 10(1):16-9. PubMed ID: 3376178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cyclosporin A on plasma lipids during the first year after renal transplantation.
    John GT; Dakshinamurthy DS; Jeyaseelan L; Jacob CK
    Natl Med J India; 1999; 12(1):14-7. PubMed ID: 10326324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations.
    Tory R; Sachs-Barrable K; Goshko CB; Hill JS; Wasan KM
    Transplantation; 2009 Jul; 88(1):62-8. PubMed ID: 19584682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of concentrations of cholesterol and triglyceride to cyclosporin A in renal transplant patients.
    Yatscoff RW; Rush D; Jeffery JR
    Clin Chem; 1986 Apr; 32(4):700. PubMed ID: 3513995
    [No Abstract]   [Full Text] [Related]  

  • 6. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
    Kimak E; Ksiazek A; Baranowicz-Gaszczyk I; Solski J
    Ren Fail; 2007; 29(6):705-12. PubMed ID: 17763166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hematocrit on cyclosporine (cyclosporin A) in whole blood and plasma of renal-transplant patients.
    Rosano TG
    Clin Chem; 1985 Mar; 31(3):410-2. PubMed ID: 3882273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of cyclosporin A between blood cells and plasma of cardiac and renal transplant recipients.
    Hamberger C; Urien S; Barre J; Brandebourger M; Lemaire M; Lang P; Buisson C; Loisance D; Cachera JP; Lagrue G
    Ther Drug Monit; 1988; 10(1):28-33. PubMed ID: 3287706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid relation ships in dialysis and renal transplant patients.
    Nicholls AJ; Cumming AM; Catto GR; Edward N; Engeset J
    Q J Med; 1981; 50(198):149-60. PubMed ID: 7029600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model to account for the blood-to-plasma distribution of cyclosporin A in human blood.
    Shibata N; Minouchi T; Ono T; Shimakawa H
    J Pharmacobiodyn; 1990 Jan; 13(1):20-9. PubMed ID: 2341967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prednisone dose spacing on plasma lipids.
    Galla JH; Curtis JJ; Woodford SY; Rees ED; Somes GW; Luke RG
    J Lab Clin Med; 1980 Jun; 95(6):801-7. PubMed ID: 6991620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol precursor concentration in plasma from patients with chronic renal failure or kidney grafts.
    Sutherland WH; Walker RJ; Ball MJ; Stapley SA; Corboy J; Robertson MC
    Clin Nephrol; 1995 Jun; 43(6):392-8. PubMed ID: 7554524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
    Antikainen M; Holmberg C; Taskinen MR
    Clin Nephrol; 1994 May; 41(5):284-9. PubMed ID: 8050208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin: pharmacokinetics and detailed studies of plasma and erythrocyte binding during intravenous and oral administration.
    Legg B; Gupta SK; Rowland M; Johnson RW; Solomon LR
    Eur J Clin Pharmacol; 1988; 34(5):451-60. PubMed ID: 3203704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective monitoring of lipid profiles in children receiving pravastatin preemptively after renal transplantation.
    Butani L
    Pediatr Transplant; 2005 Dec; 9(6):746-53. PubMed ID: 16269046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
    Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
    Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients.
    Sugioka N; Kokuhu T; Okamoto M; Yoshimura N; Ito Y; Shibata N; Takada K
    J Pharm Pharmacol; 2006 Sep; 58(9):1193-200. PubMed ID: 16945177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient profile and effect of dietary therapy on post-transplant hyperlipidemia.
    Shen SY; Lukens CW; Alongi SV; Sfeir RE; Dagher FJ; Sadler JH
    Kidney Int Suppl; 1983 Dec; 16():S147-52. PubMed ID: 6376913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute serum lipid changes in a renal transplant recipient on intravenous cyclosporin upon administration of an intravenous lipid solution.
    Bolodeoku J; Mellotte GJ
    Postgrad Med J; 1994 Nov; 70(829):849-50. PubMed ID: 7824429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.